Hormone therapies and venous thromboembolism: where are we now?

@article{Vlieg2011HormoneTA,
  title={Hormone therapies and venous thromboembolism: where are we now?},
  author={A. van Hylckama Vlieg and S. Middeldorp},
  journal={Journal of Thrombosis and Haemostasis},
  year={2011},
  volume={9}
}
Deep vein thrombosis is a common disease, with an incidence of one to three per 1000 individuals per year [1]. Numerous risk factors are known, which can be divided into genetic and acquired [2]. One of the most well-known acquired risk factors is the use of female hormones, i.e. oral contraceptive use or the use of hormone replacement therapy. Apart from the use of hormones orally, other routes of administration are also available, e.g. intrauterine devices, injectables, subcutaneous implants… Expand
Risk of venous thrombosis varies with different types of combined oral contraceptives
Hormonal contraceptives and venous thromboembolism: an epidemiological update.
Combined oral contraceptives: venous thrombosis.
Venous thromboembolism in women: a specific reproductive health risk.
Safety of medical treatments for endometriosis
Thrombosis in women: what are the knowledge gaps in 2013?
  • S. Middeldorp
  • Medicine
  • Journal of thrombosis and haemostasis : JTH
  • 2013
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 137 REFERENCES
Venous thrombosis and conjugated equine estrogen in women without a uterus.
...
1
2
3
4
5
...